NCT05548959

Brief Summary

The purpose of this study was to asses differences in nycthemeral (24-h) intraocular pressure (IOP) profiles and outflow facilities between patients who have undergone epibulbar microshunt implantation and ab interno trabeculectomy, respectively.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 13, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 22, 2022

Completed
Last Updated

September 22, 2022

Status Verified

September 1, 2022

Enrollment Period

11 months

First QC Date

September 13, 2022

Last Update Submit

September 16, 2022

Conditions

Keywords

outflow facilitymicroshuntab interno trabeculectomypneumatonometerintraocular pressure

Outcome Measures

Primary Outcomes (1)

  • Intraocular pressure variation

    24-hour variation in intraocular pressure obtained by the use of a pneumatonometer.

    Obtained 6-12 months after patients have undergone microshunt implantation and ab interno trabeculectomy, respectively. Measurements were taken at 5 points in time over 24 hours (at 5 AM, 11 AM, 4 PM, 8 PM, and midnight).

Secondary Outcomes (2)

  • Outflow facility

    Obtained 6-12 months after patients have undergone microshunt implantation and ab interno trabeculectomy, respectively. Measurements were taken at 5 points in time over 24 hours (at 5 AM, 11 AM, 4 PM, 8 PM, and midnight).

  • Intraocular pressure

    Obtained 6-12 months after patients have undergone microshunt implantation and ab interno trabeculectomy, respectively. Measurements were taken at 5 points in time over 24 hours (at 5 AM, 11 AM, 4 PM, 8 PM, and midnight).

Study Arms (2)

Microshunt patients

EXPERIMENTAL

Pneumatonometry of the intraocular pressure was performed on patients who have undergone previous microshunt implantation.

Diagnostic Test: Pneumatonometry after microshunt implantation

Ab interno trabeculectomy patientes

EXPERIMENTAL

Pneumatonometry of the intraocular pressure was performed on patients who have undergone previous ab interno trabeculectomy.

Diagnostic Test: Pneumatonometry after ab interno trabeculectomy

Interventions

Pneumatonometry was perfomed over 24 hours at 5 point in time (5 AM, 11 AM, 4 PM, 8 PM, and midnight) using a Pneumatonometer. The measurement was conducted in the habitual position.

Microshunt patients

Pneumatonometry was perfomed over 24 hours at 5 point in time (5 AM, 11 AM, 4 PM, 8 PM, and midnight) using a Pneumatonometer. The measurement was conducted in the habitual position.

Ab interno trabeculectomy patientes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients that have undergone microshunt implantation or ab interno trabeculectomy between 6-12 months ago
  • patients suffering from open-angle glaucoma

You may not qualify if:

  • Patients that have undergone microshunt implantation or ab interno trabeculectomy less than 6 months or over 12 months ago
  • patients suffering from angle-closure glaucoma

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Ophthalmology University Hospital Wuerzburg

Würzburg, Bavaria, 97070, Germany

Location

Related Links

MeSH Terms

Conditions

Glaucoma

Condition Hierarchy (Ancestors)

Ocular HypertensionEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2022

First Posted

September 22, 2022

Study Start

August 1, 2021

Primary Completion

July 1, 2022

Study Completion

July 31, 2022

Last Updated

September 22, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations